HEADER OXIDOREDUCTASE 10-FEB-16 5FVO TITLE STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN TITLE 2 IN COMPLEX WITH 6-(2-(5-(3-METHOXYPROPYLAMINO)PYRIDIN-3-YL) TITLE 3 ETHYL)-4-METHYLPYRIDIN-2-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, BRAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BNOS, CONSTITUTIVE NOS, NC-NOS, NOS TYPE I, NEURONAL NOS, COMPND 5 N -NOS, NNOS, PEPTIDYL-CYSTEINE S-NITROSYLASE NOS1, CONSTITUTIVE COMPND 6 NOS , NC-NOS, NOS TYPE I, NEURONAL NOS, N-NOS, NNOS, COMPND 7 PEPTIDYL-CYSTEINE S-NITROSYLASE NOS1, BNOS; COMPND 8 EC: 1.14.13.39; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, NITRIC OXIDE SYNTHASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION MDLTYP P ATOMS ONLY, CHAIN B AUTHOR H.LI,T.L.POULOS REVDAT 2 08-JUN-16 5FVO 1 JRNL REVDAT 1 20-APR-16 5FVO 0 JRNL AUTH H.WANG,Y.QIN,H.LI,L.J.ROMAN,P.MARTASEK,T.L.POULOS, JRNL AUTH 2 R.B.SILVERMAN JRNL TITL POTENT AND SELECTIVE HUMAN NEURONAL NITRIC OXIDE SYNTHASE JRNL TITL 2 INHIBITION BY OPTIMIZATION OF THE 2-AMINOPYRIDINE-BASED JRNL TITL 3 SCAFFOLD WITH A PYRIDINE LINKER. JRNL REF J.MED.CHEM. V. 59 4913 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27050842 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00273 REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.120 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.386 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.03 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.88 REMARK 3 NUMBER OF REFLECTIONS : 23199 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.2008 REMARK 3 R VALUE (WORKING SET) : 0.1978 REMARK 3 FREE R VALUE : 0.2545 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 2255 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 51.4007 - 5.3404 0.99 2590 137 0.1569 0.2249 REMARK 3 2 5.3404 - 4.2395 1.00 2604 145 0.1411 0.1788 REMARK 3 3 4.2395 - 3.7037 1.00 2569 159 0.1480 0.1752 REMARK 3 4 3.7037 - 3.3652 1.00 2594 158 0.1659 0.2455 REMARK 3 5 3.3652 - 3.1240 1.00 2578 144 0.1902 0.2887 REMARK 3 6 3.1240 - 2.9398 1.00 2590 155 0.2148 0.2815 REMARK 3 7 2.9398 - 2.7926 1.00 2575 142 0.2209 0.3536 REMARK 3 8 2.7926 - 2.6711 1.00 2611 157 0.2341 0.3469 REMARK 3 9 2.6711 - 2.5682 1.00 2624 118 0.2495 0.3125 REMARK 3 10 2.5682 - 2.4796 1.00 2609 137 0.2620 0.3612 REMARK 3 11 2.4796 - 2.4021 1.00 2567 149 0.2873 0.3213 REMARK 3 12 2.4021 - 2.3334 1.00 2602 128 0.2967 0.3626 REMARK 3 13 2.3334 - 2.2720 1.00 2607 137 0.3250 0.3678 REMARK 3 14 2.2720 - 2.2166 1.00 2621 140 0.3351 0.3927 REMARK 3 15 2.2166 - 2.1662 1.00 2576 113 0.3518 0.3855 REMARK 3 16 2.1662 - 2.1201 1.00 2662 136 0.3634 0.3840 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.36 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.02 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3530 REMARK 3 ANGLE : 1.180 4799 REMARK 3 CHIRALITY : 0.078 496 REMARK 3 PLANARITY : 0.005 606 REMARK 3 DIHEDRAL : 16.535 1282 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 44.2173 5.0426 22.5191 REMARK 3 T TENSOR REMARK 3 T11: 0.2551 T22: 0.2948 REMARK 3 T33: 0.2989 T12: -0.0377 REMARK 3 T13: 0.0516 T23: -0.0375 REMARK 3 L TENSOR REMARK 3 L11: 0.9460 L22: 1.7282 REMARK 3 L33: 5.1134 L12: -0.3076 REMARK 3 L13: -0.3757 L23: 1.0393 REMARK 3 S TENSOR REMARK 3 S11: -0.0666 S12: 0.0450 S13: -0.0137 REMARK 3 S21: 0.0036 S22: -0.1589 S23: 0.0612 REMARK 3 S31: -0.2735 S32: -0.3514 S33: 0.1042 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES 339-349 IN CHAIN A AND 339-347 IN CHAIN B ARE REMARK 3 DISORDERED. REMARK 4 REMARK 4 5FVO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-FEB-16. REMARK 100 THE PDBE ID CODE IS EBI-65886. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.087 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD (MAR324) REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23223 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.12 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.4 REMARK 200 R MERGE (I) : 0.11 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.00 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.4 REMARK 200 R MERGE FOR SHELL (I) : 1.50 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: OVERALL RMERGE 0.110 RPIM 0.088 CC ONE HALF 0.998 REMARK 200 HIGHEST RESOLUTION SHELL RMERGE 1.618 RPIM 1.292 CC ONE REMARK 200 HALF 0.510 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.4 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-24% PEG3350, 0.1M MES REMARK 280 0.14-0.20M AMMONIUM ACETATE, 10% ETHYLENE GLYCOL, 30UM SDS REMARK 280 5 MM GSH REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.14500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.14500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 22.45000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.10000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 22.45000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.10000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 82.14500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 22.45000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 54.10000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 82.14500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 22.45000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 54.10000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 ZN ZN A 900 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2073 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 339 REMARK 465 GLN A 340 REMARK 465 HIS A 341 REMARK 465 THR A 342 REMARK 465 ARG A 343 REMARK 465 LYS A 344 REMARK 465 PRO A 345 REMARK 465 GLU A 346 REMARK 465 ASP A 347 REMARK 465 LYS A 717 REMARK 465 GLY A 718 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CYS A 297 CB SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS A 319 OD2 ASP A 552 5555 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 309 16.55 58.44 REMARK 500 SER A 392 2.50 58.68 REMARK 500 ARG A 418 -3.65 -58.71 REMARK 500 LYS A 423 72.79 -110.45 REMARK 500 THR A 466 -76.09 -121.02 REMARK 500 PHE A 517 64.79 -104.66 REMARK 500 LYS A 550 -44.06 -133.17 REMARK 500 CYS A 582 50.08 -150.87 REMARK 500 ARG A 603 -128.65 -104.18 REMARK 500 ASN A 712 40.26 -100.65 REMARK 500 THR A 713 -72.94 -164.59 REMARK 500 VAL A 715 -72.81 -146.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM A 750 NB REMARK 620 2 HEM A 750 NA 87.8 REMARK 620 3 HEM A 750 NC 86.5 159.8 REMARK 620 4 CYS A 415 SG 99.8 102.2 97.9 REMARK 620 5 HEM A 750 ND 158.6 86.7 91.6 101.5 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 900 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 326 SG REMARK 620 2 CYS A 331 SG 98.2 REMARK 620 3 CYS A 326 SG 123.5 111.1 REMARK 620 4 CYS A 331 SG 118.7 105.5 99.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D8H A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 900 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FVP RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH HW49 REMARK 900 RELATED ID: 5FVQ RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 4-METHYL-6-(2-(5-(4- REMARK 900 METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)ETHYL)PYRIDIN-2- REMARK 900 AMINE REMARK 900 RELATED ID: 5FVR RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 4-METHYL-6-(2-(5-(1- REMARK 900 METHYLPIPERIDIN-4-YL)PYRIDIN-3-YL)ETHYL)PYRIDIN-2- REMARK 900 AMINE REMARK 900 RELATED ID: 5FVS RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 4-METHYL-6-(2-(5-(3-( REMARK 900 METHYLAMINO)PROPYL)PYRIDIN-3-YL)ETHYL)PYRIDIN-2-AMINE REMARK 900 RELATED ID: 5FVT RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 6-(2-(5-(3-(DIMETHYLAMINO) REMARK 900 PROPYL)PYRIDIN-3-YL)ETHYL)-4-METHYLPYRIDIN-2-AMINE REMARK 900 RELATED ID: 5FVU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH 4-METHYL-6-(2-(5-(4- REMARK 900 METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)ETHYL)PYRIDIN-2- REMARK 900 AMINE REMARK 900 RELATED ID: 5FVV RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH 4-METHYL-6-(2-(5-(1- REMARK 900 METHYLPIPERIDIN-4-YL)PYRIDIN-3-YL)ETHYL)PYRIDIN-2- REMARK 900 AMINE REMARK 900 RELATED ID: 5FVW RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH 4-METHYL-6-(2-(5-(3-(METHYLAMINO) REMARK 900 PROPYL)PYRIDIN-3-YL)ETHYL)PYRIDIN-2-AMINE REMARK 900 RELATED ID: 5FVX RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH HW67 REMARK 900 RELATED ID: 5FVY RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 4-METHYL-6-(2-(5-(4- REMARK 900 METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)ETHYL)PYRIDIN-2- REMARK 900 AMINE REMARK 900 RELATED ID: 5FVZ RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 6-(2-(5-(3-( REMARK 900 DIMETHYLAMINO)PROPYL)PYRIDIN-3-YL)ETHYL)-4-METHYLPYRIDIN REMARK 900 -2-AMINE REMARK 900 RELATED ID: 5FW0 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 6-(2-(5-((2-METHOXYETHYL)( REMARK 900 METHYL)AMINO)PYRIDIN-3-YL)ETHYL)-4-METHYLPYRIDIN-2- REMARK 900 AMINE DBREF 5FVO A 297 718 UNP P29476 NOS1_RAT 297 718 SEQRES 1 A 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 A 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 A 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 A 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 A 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 A 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 A 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 A 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 A 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 A 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 A 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 A 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 A 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 A 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 A 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 A 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 A 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 A 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 A 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 A 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 A 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 A 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 A 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 A 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 A 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 A 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 A 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 A 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 A 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 A 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 A 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 A 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 A 422 THR HIS VAL TRP LYS GLY HET HEM A 750 43 HET H4B A 760 17 HET D8H A 800 22 HET ZN A 900 1 HETNAM D8H 6-(2-(5-(3-METHOXYPROPYLAMINO)PYRIDIN-3-YL) HETNAM 2 D8H ETHYL)-4-METHYLPYRIDIN-2-AMINE HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM ZN ZINC ION HETSYN HEM HEME FORMUL 2 D8H C17 H24 N4 O FORMUL 3 H4B C9 H15 N5 O3 FORMUL 4 HEM C34 H32 FE N4 O4 FORMUL 5 ZN ZN 2+ FORMUL 6 HOH *76(H2 O) HELIX 1 1 THR A 315 SER A 320 5 6 HELIX 2 2 THR A 350 ILE A 369 1 20 HELIX 3 3 SER A 374 SER A 392 1 19 HELIX 4 4 LYS A 397 ASN A 411 1 15 HELIX 5 5 GLY A 417 TRP A 421 5 5 HELIX 6 6 THR A 434 ASN A 451 1 18 HELIX 7 7 LYS A 452 ASN A 454 5 3 HELIX 8 8 ASN A 498 GLN A 507 1 10 HELIX 9 9 PRO A 537 VAL A 541 5 5 HELIX 10 10 PHE A 551 GLY A 558 5 8 HELIX 11 11 GLY A 590 VAL A 595 1 6 HELIX 12 12 VAL A 595 ASP A 600 1 6 HELIX 13 13 ILE A 606 LYS A 613 1 8 HELIX 14 14 LYS A 620 SER A 623 5 4 HELIX 15 15 LEU A 624 ASP A 644 1 21 HELIX 16 16 ASP A 650 GLY A 670 1 21 HELIX 17 17 ASP A 675 VAL A 680 1 6 HELIX 18 18 SER A 684 THR A 688 5 5 HELIX 19 19 ASP A 709 THR A 713 5 5 SHEET 1 AA 2 LEU A 301 LYS A 304 0 SHEET 2 AA 2 VAL A 311 ASP A 314 -1 O LEU A 312 N VAL A 303 SHEET 1 AB 4 GLN A 425 ASP A 428 0 SHEET 2 AB 4 ALA A 458 ILE A 461 1 O ILE A 459 N PHE A 427 SHEET 3 AB 4 PHE A 584 SER A 585 -1 O SER A 585 N ALA A 458 SHEET 4 AB 4 ALA A 566 VAL A 567 -1 O VAL A 567 N PHE A 584 SHEET 1 AC 3 ARG A 473 VAL A 474 0 SHEET 2 AC 3 LEU A 522 GLN A 525 -1 O GLN A 525 N ARG A 473 SHEET 3 AC 3 GLU A 532 PHE A 534 -1 O GLU A 532 N LEU A 524 SHEET 1 AD 2 GLY A 484 LYS A 486 0 SHEET 2 AD 2 THR A 492 GLY A 494 -1 O LEU A 493 N TYR A 485 SHEET 1 AE 2 GLU A 543 PRO A 545 0 SHEET 2 AE 2 LYS A 560 TYR A 562 -1 O TRP A 561 N VAL A 544 SHEET 1 AF 3 LEU A 577 PHE A 579 0 SHEET 2 AF 3 LEU A 571 ILE A 574 -1 O LEU A 572 N PHE A 579 SHEET 3 AF 3 SER A 703 GLU A 705 -1 O SER A 703 N GLU A 573 SHEET 1 AG 2 TYR A 588 MET A 589 0 SHEET 2 AG 2 ILE A 648 VAL A 649 1 N VAL A 649 O TYR A 588 LINK SG CYS A 415 FE HEM A 750 1555 1555 2.33 LINK ZN ZN A 900 SG CYS A 326 1555 3755 2.48 LINK ZN ZN A 900 SG CYS A 331 1555 3755 2.37 LINK ZN ZN A 900 SG CYS A 331 1555 1555 2.26 LINK ZN ZN A 900 SG CYS A 326 1555 1555 2.39 CISPEP 1 THR A 701 PRO A 702 0 0.22 SITE 1 AC1 12 TRP A 409 CYS A 415 SER A 457 PHE A 584 SITE 2 AC1 12 SER A 585 TRP A 587 GLU A 592 TRP A 678 SITE 3 AC1 12 TYR A 706 H4B A 760 D8H A 800 HOH A2076 SITE 1 AC2 10 SER A 334 ARG A 596 TRP A 676 VAL A 677 SITE 2 AC2 10 TRP A 678 PHE A 691 HIS A 692 GLN A 693 SITE 3 AC2 10 GLU A 694 HEM A 750 SITE 1 AC3 9 MET A 336 GLN A 478 VAL A 567 PHE A 584 SITE 2 AC3 9 GLY A 586 TRP A 587 GLU A 592 HEM A 750 SITE 3 AC3 9 HOH A2042 SITE 1 AC4 2 CYS A 326 CYS A 331 CRYST1 44.900 108.200 164.290 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022272 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009242 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006087 0.00000